Cargando…
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach
An increase in the occurrence of viral infectious diseases is a global concern for human health. According to a WHO report, dengue virus (DENV) is one of the most common viral diseases affecting approximately 400 million people annually, with worsening symptoms in nearly 1% of cases. Both academic a...
Autores principales: | Norshidah, Harun, Leow, Chiuan Herng, Ezleen, Kamarulzaman Ezatul, Wahab, Habibah A., Vignesh, Ramachandran, Rasul, Azhar, Lai, Ngit Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971573/ https://www.ncbi.nlm.nih.gov/pubmed/36864886 http://dx.doi.org/10.3389/fcimb.2023.1061937 |
Ejemplares similares
-
Computational study of nitro-benzylidene phenazine as dengue virus-2 NS2B-NS3 protease inhibitor
por: Salin, Nurul Hanim, et al.
Publicado: (2022) -
Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling
por: Hariono, Maywan, et al.
Publicado: (2019) -
3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors
por: Osman, Hasnah, et al.
Publicado: (2017) -
Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
por: Norshidah, Harun, et al.
Publicado: (2021) -
Development of a NS2B/NS3 protease inhibition assay using AlphaScreen(®) beads for screening of anti-dengue activities
por: Abduraman, Muhammad Asyraf, et al.
Publicado: (2018)